JWCA
BNGO icon

J.W. Cole Advisors’s Bionano Genomics BNGO Stock Holding History

J.W. Cole Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25
Closed -$9.15K – 742
2023
Q2 		$9.15K Sell
25
-7
-22% -$3.16K ﹤0.01% 754
2023
Q1 		$21.6K Hold
32
– – ﹤0.01% 769
2022
Q4 		$28.4K Hold
32
– – ﹤0.01% 734
2022
Q3 		$36K Hold
32
– – ﹤0.01% 716
2022
Q2 		$27K Hold
32
– – ﹤0.01% 726
2022
Q1 		$50K Buy
32
+3
+10% +$4.05K ﹤0.01% 796
2021
Q4 		$52K Sell
29
-8
-22% -$21.4K ﹤0.01% 825
2021
Q3 		$121K Hold
37
– – 0.01% 460
2021
Q2 		$161K Buy
37
+2
+6% +$7.9K 0.01% 714
2021
Q1 		$170K Buy
35
+2
+6% +$11.3K 0.02% 643
2020
Q4 		$62K Buy
+33
New +$12.3K 0.01% 620

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

J.W. Cole Advisors's BNGO Position: Q3 2023 in Review

J.W. Cole Advisors sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 25 shares — an estimated $9.15K sold.

J.W. Cole Advisors first reported a position in BNGO in Q4 2020 and held it in 11 quarters. The position peaked at $170K in Q1 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • J.W. Cole Advisors reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • J.W. Cole Advisors sold 25 Bionano Genomics shares in Q3 2023, an estimated $9.15K.
  • J.W. Cole Advisors first reported a position in Bionano Genomics in Q4 2020 and held it in 11 quarters.
  • J.W. Cole Advisors's Bionano Genomics position peaked at $170K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on J.W. Cole Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.